Rating Change
Piper Sandler reiterated its Overweight rating on AbbVie Inc. (NYSE:ABBV) on August 20, 2026.
reiterateNYSE:ABBV
Piper Sandler Reiterates Overweight Rating on AbbVie Inc. (ABBV)
Piper Sandler reiterated its Overweight rating on AbbVie Inc. (NYSE:ABBV) on August 20, 2026.
At publication ·
What changed
AbbVie Inc. (NYSE:ABBV) · reiterate
- Firm
- Piper Sandler
- Rating
- Overweight to Overweight
- Price at event
- $261.83
- Market capitalization
- $410.1B
At a glance
Key takeaways
- Piper Sandler reiterated an Overweight rating on AbbVie (ABBV) on August 20, 2026, with the stock trading at $261.83 and a market capitalization of $410.1 billion.
Market Context
AbbVie Inc. operates in the Healthcare sector. The stock currently trades at $261.83 with a market capitalization of $410.1B. The stock has gained 15.0% over the past 52 weeks.
Analyst coverage from Piper Sandler provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for AbbVie Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for AbbVie Inc.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 20, 2026 | Piper Sandler | Overweight | N/A |
| Aug 17, 2026 | Wells Fargo | Overweight | N/A |
| Aug 13, 2026 | Wolfe Research | Outperform | N/A |
| Aug 11, 2026 | BNP Paribas | Neutral | N/A |
| Aug 10, 2026 | Evercore ISI Group | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View ABBV Stock Page
Frequently Asked Questions
What does the Overweight rating mean for ABBV?
A rating of Overweight from Piper Sandler reflects the analyst's outlook on AbbVie Inc. (NYSE:ABBV). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ABBV forecast page.